BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart Procedures Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart Procedures

Read the original here:
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies

Related Post